Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “In Situ Carcinoma”

594 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 594 results

Testing effectiveness (Phase 2)Looking for participantsNCT06617455
What this trial is testing

Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Michigan Rogel Cancer Center 36
Not applicableStudy completedNCT00874458
What this trial is testing

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 40
Not applicableLooking for participantsNCT06401304
What this trial is testing

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)

Who this might be right for
Breast CancerBreast Carcinoma in SituBreast Cancer Invasive+1 more
Uppsala University 1,200
Not applicableStudy completedNCT02281487
What this trial is testing

Hysterectomy for Benign Gynaecological Conditions With or Without Tubectomy

Who this might be right for
Abdominal Hysterectomy (& Wertheim)
Gynaecologisch Oncologisch Centrum Zuid 105
Not applicableStudy completedNCT04999917
What this trial is testing

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer InvasiveBreast Cancer in Situ
XEOS Medical 206
Not applicableLooking for participantsNCT05318274
What this trial is testing

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Who this might be right for
Ductal Breast Carcinoma in SituInvasive Breast CancerEarly-stage Breast Cancer+4 more
Coordinación de Investigación en Salud, Mexico 72
Large-scale testing (Phase 3)Study completedNCT00106691
What this trial is testing

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

Who this might be right for
Preneoplastic ConditionsProstatic Intraepithelial Neoplasia
GTx 1,589
Not applicableStudy completedNCT00602628
What this trial is testing

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Not applicableStudy completedNCT00535977
What this trial is testing

Broccoli, Peas and PIN

Who this might be right for
Prostatic Intraepithelial Neoplasia
Quadram Institute Bioscience 22
Testing effectiveness (Phase 2)Study completedNCT00090857
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 49
Testing effectiveness (Phase 2)Looking for participantsNCT06677944
What this trial is testing

Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Yonsei University 47
Testing effectiveness (Phase 2)Study completedNCT00416403
What this trial is testing

Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Francisco 35
Not applicableLooking for participantsNCT02389673
What this trial is testing

Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer

Who this might be right for
Breast Neoplasms
Liao Ning 222
Testing effectiveness (Phase 2)Looking for participantsNCT05865028
What this trial is testing

A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

Who this might be right for
Oropharyngeal DysplasiaOral Cavity DysplasiaOral Carcinoma in Situ
Elizabeth J Franzmann 32
Not applicableStudy completedNCT04245657
What this trial is testing

Factors Affecting Functionality in Breast Cancer Survivors

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer Lymphedema+3 more
Izmir Bakircay University 111
Not applicableLooking for participantsNCT06919809
What this trial is testing

Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery

Who this might be right for
Wound Healing After MMS SurgeryBCC - Basal Cell CarcinomaSCC - Squamous Cell Carcinoma+1 more
McGuire Institute 16
Not applicableWithdrawnNCT02817607
What this trial is testing

Study to Assess Breast Sensation Before and After Breast Cancer Treatment

Who this might be right for
Breast ReconstructionDuctal Carcinoma In-situ
Duke University
Early research (Phase 1)Study completedNCT00290732
What this trial is testing

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableLooking for participantsNCT04057209
What this trial is testing

VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer

Who this might be right for
Glottis TumorLarynx Cancer
Olgun Elicin 34
Not applicableStudy completedNCT01097278
What this trial is testing

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
SWOG Cancer Research Network 208
Load More Results